Anterior key facts
as of Oct 2026- Developer of a clinical AI platform designed to transform and automate health plan workflows with measurable results.
- Anterior is valued at approximately $151.2M as of Oct 2026 (last reported valuation).
- It has raised $63.3M; the latest was Early Stage VC ($40.0M) in Feb 2026.
- Notable investors include Sequoia Capital, New Enterprise Associates, Avra, Ventures Together, FPV Ventures — 16 tracked in total.
- Status: Privately Held (backing).
Anterior's last reported valuation, Feb 2026. Nothing priced has surfaced since.
- ·The complete investor list: 16 names
- ·Watch Anterior: the Monday email on marks, rounds and moves
Anterior funding rounds
No funding rounds for Anterior are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Anterior
16+Anterior valuation
Anterior's last reported valuation was $151 million in Feb 2026. No priced round, secondary trade or fund mark has surfaced since.
Anterior investors
16 investors are on record for Anterior, including Sequoia Capital, New Enterprise Associates, Avra and Ventures Together. By type, the record holds 4 venture capital firms and 1 angel investor.
About Anterior
Developer of a clinical AI platform designed to transform and automate health plan workflows with measurable results. The company's platform offers modular AI actions, configurable workflow automation, and clinically validated models with transparent orchestration, enabling health plans to reduce administrative burden, improve clinical accuracy, and achieve faster operational efficiency.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 8
- Website
- anterior.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.